ask="42.20"
ask_size="700"
average_daily_volume="1579740"
bid="41.00"
bid_size="300"
book_value="11.83"
change="+0.52"
change_from_200_day_moving_average="-14.05"
change_from_50_day_moving_average="-0.75"
change_from_52_week_high="-46.34"
change_From_52_week_low="10.39"
change_in_percent="+1.26%"
close="41.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.80"
eps_estimate_next_quarter="-1.33"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="70877000"
high="42.20"
high_52_weeks="88.11"
last_trade_date="1/12/2017"
last_trade_price="41.77"
last_trade_size="100"
last_trade_time="3:59pm"
low="40.28"
low_52_weeks="31.38"
market_capitalization="3.58B"
moving_average_200_day="55.82"
moving_average_50_day="42.52"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="63.36"
open="41.03"
pe_ratio="N/A"
peg_ratio="-0.20"
percent_change_from_200_day_moving_average="-25.17%"
percent_change_from_50_day_moving_average="-1.77%"
percent_change_from_52_week_high="-52.59%"
percent_change_from_52_week_low="+33.11%"
previous_close="41.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.49"
price_per_sales="95.01"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="5.52"
stock_exchange="NMS"
symbol="ALNY"
volume="660037"
weeks_range_52="31.38 - 88.11"
